---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-053752"
form_type: "8-K"
ticker: "INKT"
cik: "0001840229"
company_name: "MiNK Therapeutics, Inc."
filed_at: "2023-10-17T23:59:59+00:00"
generated_at: "2026-06-09T22:46:55.035586+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# MiNK Therapeutics director Dr. John Baldoni resigns effective Oct 31, 2023

## Summary
- Dr. John Baldoni resigns from board effective Oct 31, 2023, citing manufacturing advancements reducing need for his technical contributions.
- He will serve as ad hoc technical advisor to the Company following his departure.
- Baldoni did not step down due to any disagreement with MiNK's operations, policies, or practices.
- Notice of resignation was sent on October 12, 2023; effective October 31, 2023.

## SEC filing metadata
- accession: 0000950170-23-053752
- form_type: 8-K
- ticker: INKT
- cik: 0001840229
- company_name: MiNK Therapeutics, Inc.
- filed_at: 2023-10-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840229/000095017023053752/0000950170-23-053752-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840229/000095017023053752/inkt-20231012.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-053752
- JSON: https://secwatch.observer/filing/0000950170-23-053752.json
- Plain text: https://secwatch.observer/filing/0000950170-23-053752.txt

## Key facts
- Executive change
  Dr. John Baldoni resigned as director at MiNK Therapeutics, Inc..
  - Action: resigned
  - Role: director
  source text: On October 12, 2023, Dr. John Baldoni sent notice of his resignation as a director at MiNK Therapeutics, Inc. (the "Company"), effective October 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840229/000095017023053752/0000950170-23-053752-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.